Latest filing published 14 Sept 2018 for Evolent Health, Inc., €230k.
Filing timeline
BuySaleInsider track record
Thomas Peterson III: trading record in brief
All filings by Thomas Peterson III on record concern Evolent Health, Inc. The record holds 25 filings, for trades running from 1 March 2016 to 13 September 2018.
Sales make up the whole of the open-market record (18 sales, €9.5M). The rest of the record consists of 3 share grants and 4 option exercises. So far in 2018, the count stands at no purchases and 6 sales.
The record was last updated on 14 September 2018 with an option exercise (€230k) in Evolent Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas Peterson III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 70,000 shares@ US$3.847.2% of flowClass A Common StockSEC:0001628908-18-000070:0
- 70,000 shares@ US$27.5051.4% of flowClass A Common StockSEC:0001628908-18-000070:1
- 30,000 shares@ US$25.0020.1% of flowClass A Common StockSEC:0001628908-18-000067:0
- 10,000 shares@ US$19.965.3% of flowClass A Common StockSEC:0001628908-18-000060:0
- 10,000 shares@ US$21.214.4% of flowClass A Common StockSEC:0001628908-18-000055:0
- 10,000 shares@ US$20.041.9% of flowClass A Common StockSEC:0001628908-18-000037:0
- 10,000 shares@ US$18.911.8% of flowClass A Common StockSEC:0001628908-18-000033:0
- 25,090 shares0Class A Common StockSEC:0001628908-18-000007:0
- 14,033 shares@ US$3.840.5% of flowClass A Common StockSEC:0001628908-17-000037:0
- 14,033 shares@ US$26.003.5% of flowClass A Common StockSEC:0001628908-17-000037:1
- 26,507 shares@ US$26.006.7% of flowClass A Common StockSEC:0001628908-17-000037:2
- 57,433 shares@ US$24.3014.2% of flowClass A Common StockSEC:0000950157-17-000722:0
- 20,777 shares@ US$24.995.3% of flowClass A Common StockSEC:0001643498-17-000003:1
- 20,777 shares@ US$25.005.3% of flowClass A Common StockSEC:0001643498-17-000003:0
- 9,328 shares@ US$3.840.4% of flowClass A Common StockSEC:0001643498-17-000002:0
- 9,328 shares@ US$25.002.4% of flowClass A Common StockSEC:0001643498-17-000002:1
- 17,114 shares@ US$25.004.5% of flowClass A Common StockSEC:0001643498-17-000002:2
- 6,265 shares@ US$25.001.6% of flowClass A Common StockSEC:0001643498-17-000001:1
- 12,339 shares@ US$25.003.2% of flowClass A Common StockSEC:0001643498-17-000001:2
- 6,265 shares@ US$3.840.3% of flowClass A Common StockSEC:0001643498-17-000001:0
- 13,699 shares0Class A Common StockSEC:0000950157-17-000196:0
- 72,827 shares@ US$21.5415.8% of flowClass A Common StockSEC:0000950157-16-002177:0
- 21,908 shares0Class A Common StockSEC:0001140361-16-056454:0
23 of 23 declarations
